NEUtekBio Limited
nEUtekBio was founded in 2001 to commercialise novel diagnostic and prognostic assays aimed at increasing the efficacy of critical drug treatments involving Interferons and other Cytokines.
These assays will address large and important market segments in the areas of autoimmune disease and infectious disease. nEUtekBio operates from a Galway base and leverages its research programs through its collaboration agreement with the Centre National de la Recherche Scientifique (CNRS) in Paris.

www.neutekbio.com ->